Vertex Pharma (VRTX) Tops Q1 EPS by 14c, Misses on Revenue; Offers FY26 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 558.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $558.88 | 52 Week High | $134.71 | |||
| Open | $558.88 | 52 Week Low | $73.31 | |||
| Day High | $558.88 | P/E | N/A | |||
| Day Low | $558.88 | EPS | $-1.98 | |||
| Volume | 145,018 | |||||
